Junk food companies are starting to get nervous over how many Americans use GLP-1 medications to lose weight.
Washington Post columnist Catherine Rampell walked through shocking details of the economic impact of drugs like Wegovy and Ozempic cited in a new study by Cornell University and Numerator.
"Some junk-food companies and alcohol sellers are freaking out about the prospect of reduced appetites or booze cravings. As they should," Rampell said, citing data showing a substantial reduction in grocery spending...